Picture of Chemomab Therapeutics logo

CMMB — Chemomab Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Founders

Nov 16 (Reuters) - Chemomab Therapeutics Ltd  CMMB.O :
    * CHEMOMAB THERAPEUTICS LTD- ON NOV 14,ECONOMIC COURT OF
TEL-AVIV,
ISRAEL, APPROVED CO'S PETITION TO ENTER INTO REPURCHASE
ARRANGEMENT WITH CO-FOUNDERS
    * CHEMOMAB THERAPEUTICS LTD - INTENDS TO REPURCHASE ENTIRE
AMOUNT
OF 582,023 OF CO-FOUNDERS' ADSS FOR TOTAL CONSIDERATION OF ABOUT
$1.2 MILLION
    * CHEMOMAB THERAPEUTICS LTD - CASH RUNWAY IS EXPECTED TO
LAST
THROUGH END OF 2023, CONSISTENT WITH LAST QUARTERLY UPDATE
PROVIDED BY CO
    * CHEMOMAB THERAPEUTICS LTD - DOES NOT EXPECT ANY CHANGE IN
ITS
CASH RUNWAY AS A RESULT OF THE REPURCHASE ARRANGEMENT

Source text : (http://bit.ly/3UF9f8R)
Further company coverage:  CMMB.O 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Chemomab Therapeutics

See all news